SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000880771-16-000140
Filing Date
2016-05-10
Accepted
2016-05-10 13:29:34
Documents
56
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scln-20160331x10q.htm 10-Q 1189815
2 EX-31.1 scln-20160331xex31_1.htm EX-31.1 18215
3 EX-31.2 scln-20160331xex31_2.htm EX-31.2 18229
4 EX-32.1 scln-20160331xex32_1.htm EX-32.1 12496
5 EX-32.2 scln-20160331xex32_2.htm EX-32.2 15349
  Complete submission text file 0000880771-16-000140.txt   4193929

Data Files

Seq Description Document Type Size
6 EX-101.INS scln-20160331.xml EX-101.INS 811833
7 EX-101.SCH scln-20160331.xsd EX-101.SCH 31950
8 EX-101.CAL scln-20160331_cal.xml EX-101.CAL 42106
9 EX-101.DEF scln-20160331_def.xml EX-101.DEF 73487
10 EX-101.LAB scln-20160331_lab.xml EX-101.LAB 226881
11 EX-101.PRE scln-20160331_pre.xml EX-101.PRE 192179
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19825 | Film No.: 161634867
SIC: 2834 Pharmaceutical Preparations